Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?

Dalbagni, G; Rechtschaffen, T; Herr, H W

Dalbagni, G; Rechtschaffen, T; Herr, H W.

Affiliation

Dalbagni G; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

J Urol ; 162(3 Pt 1): 708-9, 1999 Sep.

Article in En | MEDLINE | ID: mdl-10458348

Subject(s)

Adjuvants, Immunologic/therapeutic use; BCG Vaccine/therapeutic use; Biopsy/statistics & numerical data; Carcinoma, Transitional Cell/drug therapy; Carcinoma, Transitional Cell/pathology; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/pathology; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Time Factors; Urethra

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Biopsy / Urinary Bladder Neoplasms / BCG Vaccine / Carcinoma, Transitional Cell / Adjuvants, Immunologic Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 1999 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links